Nautic Partners Selling Medigen for $225 Million

Nautic Partners has agreed to sell Medegen, a Scottsdale, Ariz.-based developer of infusion therapy solutions, to CareFusion Corp. (NYSE: CFN). The deal is valued at $225 million in cash.

5 April 2010•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail